Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Welsh

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Liver Cancer|January 26, 2026
Proton Radiotherapy Alone versus Combined with Immunotherapies or Tyrosine Kinase Inhibitors for Barcelona Clinic Liver Cancer Stage B or C Hepatocellular CarcinomaRodney Cheng-En Hsieh, Willy Po-Yuan Chen, Jin-Chiao Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005Kristin A Higgins, Chen Hu, Helen J Ross, et al.
Cancer Discovery|September 11, 2012
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1Lauren Averett Byers, Jing Wang, Monique B Nilsson, et al.
Journal for Immunotherapy of Cancer|July 4, 2023
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trialMehmet Altan, Yan Wang, Juhee Song, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2024
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy DeferralStephanie O Dudzinski, Maria E Cabanillas, Sarah Hamidi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2020
Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation TherapyRobert J Griffin, Mansoor M Ahmed, Beatriz Amendola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2018
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017Paul Okunieff, Katherine Casey-Sawicki, Natalie A Lockney, et al.
Oncoimmunology|June 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conferenceFabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, et al.
The Lancet. Oncology|March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translationZachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Genome Research|June 26, 2013
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancerHui Ling, Riccardo Spizzo, Yaser Atlasi, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Liver Cancer|January 26, 2026
Proton Radiotherapy Alone versus Combined with Immunotherapies or Tyrosine Kinase Inhibitors for Barcelona Clinic Liver Cancer Stage B or C Hepatocellular CarcinomaRodney Cheng-En Hsieh, Willy Po-Yuan Chen, Jin-Chiao Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005Kristin A Higgins, Chen Hu, Helen J Ross, et al.
Cancer Discovery|September 11, 2012
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1Lauren Averett Byers, Jing Wang, Monique B Nilsson, et al.
Journal for Immunotherapy of Cancer|July 4, 2023
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trialMehmet Altan, Yan Wang, Juhee Song, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2024
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy DeferralStephanie O Dudzinski, Maria E Cabanillas, Sarah Hamidi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2020
Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation TherapyRobert J Griffin, Mansoor M Ahmed, Beatriz Amendola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2018
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017Paul Okunieff, Katherine Casey-Sawicki, Natalie A Lockney, et al.
Oncoimmunology|June 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conferenceFabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, et al.
The Lancet. Oncology|March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translationZachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Genome Research|June 26, 2013
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancerHui Ling, Riccardo Spizzo, Yaser Atlasi, et al.
Pageof 11